Vaccine Response Clinical Trials

5 recruiting

Vaccine Response Trials at a Glance

10 actively recruiting trials for vaccine response are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Phase 4 with 5 trials, with the heaviest enrollment activity in Adelaide, Atlanta, and Decatur. Lead sponsors running vaccine response studies include Emory University, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, and Central Adelaide Local Health Network Incorporated.

Browse vaccine response trials by phase

Treatments under study

About Vaccine Response Clinical Trials

Looking for clinical trials for Vaccine Response? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Vaccine Response trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Vaccine Response clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Not Applicable

Safety and Immunogenicity of Recombinant Zoster Vaccine for Transplant Recipients

ImmunosuppressionVaccine Response Impaired
Central Adelaide Local Health Network Incorporated160 enrolled1 locationNCT06262776
Recruiting

Impact Of Kidney Failure On The Regulation Of Humoral Response To Vaccination

Chronic Kidney Disease Requiring Chronic DialysisVaccine Response
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico146 enrolled3 locationsNCT06635525
Recruiting

Is a Third Dose of MMRV Vaccine Beneficial for the Adult Population in Alberta?

Vaccination FailureVaccine Response Impaired
University of Alberta200 enrolled1 locationNCT05923970
Recruiting
Phase 4

Antibiotics and Vaccine Immune Responses Study

Vaccine Response Impaired
South Australian Health and Medical Research Institute348 enrolled1 locationNCT06148025
Recruiting
Phase 3

RSV Vaccine in Transplant Recipients

Immune SuppressionVaccine Response ImpairedRespiratory Syncytial Virus Infections
University Health Network, Toronto100 enrolled1 locationNCT06593210
Recruiting
Phase 4

Characterizing the Human Airway Immune Response to FluMist Vaccination

Healthy Young AdultsInfluenza VaccinesInfluenza Vaccine Response
Washington University School of Medicine30 enrolled1 locationNCT07177417
Recruiting
Phase 1

Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COVID-19 Vaccine

Vaccine Response
The Methodist Hospital Research Institute75 enrolled1 locationNCT06821100
Recruiting
Phase 4

Durability of Vaccine Responses

Vaccine Response
Emory University66 enrolled3 locationsNCT05801978
Recruiting
Phase 4

Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients

COVID-19ImmunosuppressionVaccine Response Impaired
University of California, Davis50 enrolled1 locationNCT05060991
Recruiting
Phase 4

A Deep Longitudinal Analysis of Next Generation Influenza Vaccines in Older Adults

AgingVaccine ResponseInfluenza Vaccine+1 more
The Jackson Laboratory75 enrolled1 locationNCT05518500